|
Catalog Number SEPX-8-6-40-135 |
Device Problem
Activation, Positioning or Separation Problem (2906)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/18/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that an attempt was made to use a protégé rx to treat a plaque lesion in the mid carotid artery - common. degree of tortuosity was little. degree of calcification was none.Lesion stenosis was 75%.A 6f sheathe french was used.A 14 guidewire was used.Nav6 embolic protection was used.Device was prepped per ifu.The lesion was pre-dilated with a 4mm inflation device.The device did not pass through a previously-deployed stent.Resistance was not encountered when advancing the device.Excessive force was not used.The was partial deployment.There was no damage to the deployment mechanisms or device handle prior to deployment issue.Thumbscrew/lock-pin was checked for securement prior to procedure.Lock-pin was removed before deployment.It was reported that after the guide wire was in place, the spider was placed.After the balloon was expanded, the stent was placed.The stent was deployed a little but could not be deployed.It was taken out of the body, no intervention was required for removal of the stent and was re placed with another stent.After implantation, after checking the effect with angiography, the spider was removed.No patient injury reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Product analysis the device was returned with the touhy-borst tightened and the strain relief was away from the y connector on the device the stent confirmed as 40mm the device was returned with approx.15mm of stent exposed kinks were noted on the device at approx.16.5cm, 18cm and 19cm from the distal tip a 20cc water filled syringe was used to flush the device, the device would not flush.A 0.014¿ guidewire was loaded through the guidewire lumen and would not advance passed the kinks on the device.The device was loaded into a deployment fixture the stent could not be deployed with a maximum peak force of 5.50lbs medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|